Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Epileptiform discharges are associated with increased theta activity over time in patients with Lewy body dementia.

Neuroscience·2026

Same author

Morbidity and medication use preceding a diagnosis of late-onset Alzheimer's disease: a Danish nationwide study.

Journal of neurology·2026

Same author

Associations between a psychosocial intervention and quality of life and caregiver-related outcomes in family caregivers of people with dementia: the Danish DemTool trial.

BMC geriatrics·2026

Same author

Plasma phosphorylated tau217 discordance with amyloid status in an ethnically diverse mixed memory clinic cohort.

Journal of the neurological sciences·2026

Same author

A pilot study on the effect of feed supplementation with magnesium oxide and magnesium aspartate on blood magnesium content and tail lesions in pigs under practical on-farm conditions.

Porcine health management·2026

Same author

Epileptiform discharges in neurodegenerative diseases linked to atrophy but not associated with iron depositions.

GeroScience·2026

Search research articles

Related Experiment Video

Updated: Feb 17, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Communicating Identifiability Risks to Biobank Donors.

T J Kasperbauer, Mickey Gjerris, Gunhild Waldemar

Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees

|December 8, 2017

Summary

This summary is machine-generated.

Protecting privacy in healthcare and genomics research is crucial. This study explores how to effectively communicate identifiability risks to donors during the consent process for data donation and research.

More Related Videos

Creation and Maintenance of a Living Biobank - How We Do It

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Experiment Videos

Last Updated: Feb 17, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Creation and Maintenance of a Living Biobank - How We Do It

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Area of Science:

Bioethics
Health Informatics
Genomic Research Ethics

Background:

Recent privacy breaches in healthcare and genomics research highlight inadequate data protection standards.
Advancements in de-identification and widespread data sharing increase the risk of individuals being tracked across databases.
Existing ethical discussions primarily focus on mitigating identifiability risks rather than communicating them to donors.

Purpose of the Study:

To examine ethical arguments for different risk communication strategies in research consent.
To address the gap in discussing how to inform potential donors about identifiability risks.
To propose methods for incorporating identifiability concerns into the consent process.

Main Methods:

Review of ethical arguments concerning risk communication in informed consent.
Analysis of current practices in communicating data sharing and identifiability risks.
Development of frameworks for detailed and simplified risk communication methods.

Main Results:

Identifiability risks in data sharing are a growing concern due to technological advancements.
Effective communication of these risks to potential donors is ethically imperative.
Both detailed and simplified approaches can be adapted to convey identifiability concerns during consent.

Conclusions:

Ethical frameworks support tailored communication of identifiability risks in research consent.
Improving risk communication can enhance donor understanding and trust in healthcare and genomics research.
Implementing clear communication strategies is essential for responsible data stewardship and participant engagement.